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Background: The aim of this study was to investigate the prevalence of obesity in Korean men with Klinefelter syndrome (KS) and 
the associated risk factors for obesity and hyperglycemia.
Methods: Data were collected retrospectively from medical records from 11 university hospitals in Korea between 1994 and 2014. 
Subjects aged ≥18 years with newly diagnosed KS were enrolled. The following parameters were recorded at baseline before treat-
ment: chief complaint, height, weight, fasting glucose level, lipid panel, blood pressure, testosterone, luteinizing hormone, follicle-
stimulating hormone, karyotyping patterns, and history of hypertension, diabetes, and dyslipidemia.
Results: Data were analyzed from 376 of 544 initially enrolled patients. The rate of the 47 XXY chromosomal pattern was 94.1%. 
The prevalence of obesity (body mass index ≥25 kg/m2) in Korean men with KS was 42.6%. The testosterone level was an indepen-
dent risk factor for obesity and hyperglycemia.
Conclusion: Obesity is common in Korean men with KS. Hypogonadism in patients with KS was associated with obesity and hy-
perglycemia.
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INTRODUCTION
Klinefelter syndrome (KS) is the most frequent sex chromo-
some disorder in men, with a prevalence of 1:500 to 1:1,000 
live births [1]. KS is caused by the presence of one or more ad-
ditional X chromosomes. The 47 XXY karyotype is the most 
common classical chromosomal abnormality in subjects with 
KS, although both mosaic patterns and KS variants with super-
numerary X or Y chromosomes exist [2]. The classical KS phe-
notype is a tall, slender man with narrow shoulders, long arms 
and legs, small testes, micropenis, gynecomastia, a lack of pubic 
hair, infertility, and mild-to-moderate cognitive deficits [3]. 
However, many patients do not present with the classical symp-
toms, and men with KS are associated with a broad spectrum of 
phenotypes, professions, incomes, and socioeconomic statuses 
[1,3,4]. KS in most men remains undetected, and only 25% of 
those predicted to have KS are diagnosed [5]. Although it is un-
known why so many men with KS go their entire lives undiag-
nosed, it may be due to the lack of pronounced features, since 
the genotype does not necessarily imply the presence of any 
classical phenotypic features [6,7]. Recent studies reported that 
KS is associated with abdominal obesity and an increased risk 
of metabolic syndrome [8,9]. However, only limited data such 
as case reports describing obesity and metabolic disorders are 
available in Korean men with KS [10-13]. Therefore, the cur-
rent study investigated the prevalence of obesity in Korean men 
with KS and the associated risk factors for obesity and hyper-
glycemia.
METHODS
Subjects
Medical record data were collected retrospectively from 11 uni-
versity hospitals in South Korea willing to participate from 
1994 to 2014. Subjects aged ≥18 years with newly diagnosed 
KS were enrolled. The following parameters were examined at 
baseline before treatment: chief complaint, height, weight, fast-
ing glucose level, lipid panel, blood pressure, total testosterone, 
luteinizing hormone (LH), follicle-stimulating hormone (FSH), 
sex chromosomal abnormalities, and histories of hypertension, 
diabetes, and dyslipidemia. Data from 376 of the 544 patients 
initially enrolled were analyzed. One hundred and sixty-eight 
patients were excluded due to an inaccurate diagnosis or miss-
ing data regarding body weight, height, or testosterone level. 
The study was approved by the Institutional Review Boards of 
Ajou University Hospital and each hospital, and it conformed to 
the ethical guidelines of the Declaration of Helsinki. Patient re-
cords and information were anonymized and de-identified be-
fore analysis.
Definition
KS was defined based on a karyotype consisting of X-chromo-
some polysomy and at least one Y chromosome, either as a sin-
gle lineage or mosaicism. The definition of obesity was a body 
mass index (BMI) ≥25 kg/m2 [14]. Diabetes was defined as 
fasting plasma glucose (FPG) ≥126 mg/dL, glycated hemoglo-
bin (HbA1c) ≥6.5%, or current treatment with oral antidiabetes 
drugs or insulin [15]. Prediabetes was defined as FPG between 
100 and 125 mg/dL or an HbA1c of 5.7% to 6.4% and no diag-
nosis of diabetes [15]. Hyperglycemia was diagnosed if the pa-
tient had diabetes, used hypoglycemic agents, or had a FPG ≥
100 mg/dL or an HbA1c level ≥5.7%. Hypertension was diag-
nosed according to a systolic blood pressure ≥130 mm Hg, dia-
stolic blood pressure ≥85 mm Hg, or the use of antihyperten-
sive medications [16]. Dyslipidemia was defined as a serum to-
tal cholesterol level ≥240 mg/dL, triglyceride level ≥150 mg/dL, 
low serum high density lipoprotein cholesterol level (<40 mg/dL 
in men and <50 mg/dL in women), or the use of lipid-lowering 
agents [17].
Statistical analysis
All continuous variables were expressed as mean±standard de-
viation except age. Independent t tests were used to analyze 
continuous data. Age was shown as median and total range and 
nonparametric test was used to test for differences between 
groups. Categorical variables are expressed as numbers and per-
centages. Chi-square tests were implemented for categorical 
data, as appropriate. Pearson correlation analysis was used to 
describe correlations between variables, and logistic regression 
analysis was used to evaluate the factors associated with obesity 
or hyperglycemia. The data were analyzed using SPSS version 
22.0 (IBM Co., Armonk, NY, USA). A two-sided P<0.05 was 
considered statistically significant.
RESULTS
The chief complaints of patients with KS at diagnosis are shown 
in Table 1. The most common complaints were (in order) infer-
tility, small testicles, sexual dysfunction, and gynecomastia. Ta-
ble 2 shows the karyotyping results in patients with KS. The 
proportions of nonmosaic, mosaic, and KS variants were 94.1%, 
3.5%, and 2.5%, respectively. The mean patient age and BMI 
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were 32.5±5.9 years and 24.7±3.9 kg/m2, respectively (Table 
3). The prevalence of obesity in patients with KS was 42.6%. 
We found a trend towards an increase in the prevalence of obe-
sity according to age, but there was no significant difference in 
a subgroup analysis (18 to 29 years [37.5%] vs. 30 to 39 years 
[43.1%] vs. 40 to 55 years [52.9%], P=0.122). The prevalences 
of hyperglycemia and dyslipidemia were 38.8% and 19.1%, re-
spectively.
Obese subjects with KS had a high incidence of hyperglyce-
mia and low testosterone level and elevated LH and FSH levels 
compared with nonobese patients with KS. Testosterone levels 
were negatively correlated with BMI (r=–0.178, P=0.001) and 
FPG levels (r=–0.147, P=0.030) (Fig. 1). In a logistic regres-
sion model using obesity as the dichotomous variable, testoster-
one was the only independent risk factor after adjusting for age 
and karyotype (classical vs. nonclassical KS; odds ratio, 0.797; 
95% confidence interval, 0.671 to 0.948; P=0.010). In a model 
using hyperglycemia as the dependent variable, testosterone 
level, BMI, and age were independent risk factors after exclu-
sion of the karyotyping pattern.
Table 1. Chief Complaint at Diagnosis
Chief complaint Number of patients (%)
Infertility 275 (73.1)
Small testicles 37 (9.8)
Sexual dysfunction 29 (7.7)
Gynecomastia 12 (3.2)
Genetic counselling 9 (2.4)
Delayed secondary sexual characteristics 5 (1.3)
Other reason 9 (2.4)
Table 2. Karyotyping of Patients with Klinefelter Syndrome 
Karyotype Number of patients (%)
47 XXY 354 (94.1)
46 XY/47 XXY 13 (3.5)
46 XY/47 XXY/48 XXXY 3 (0.8)
48 XXXY 2
48 XXYY 1
46 XY/46 XX/47 XXY 1
47 XX, inv (Y) 1
47 XXY/48 XXXY 1
Table 3. Comparison of Characteristics in Obese versus Nonobese Patients with Klinefelter Syndrome 
Characteristic Total (n=376) Nonobese (n=216) Obese (n=160) P value
Age, yr 32 (18–53) 32 (18–53) 32 (20–53) 0.430
Height, cm 177.0±6.5 177.1±6.3 177.0±6.9 0.904
Body weight, kg 77.5±13.8 69.2±8.8 88.8±11.1 <0.001
BMI, kg/m2 24.7±3.9 22.0±2.2 28.3±2.7 <0.001
Hypertension 57 (15.2) 27 (12.5) 30 (18.8) 0.095
Hyperglycemiaa 85 (38.8) 38 (31.4) 47 (48.0) 0.012
   Prediabetes 57 (26.0) 24 (19.8) 33 (33.7)
   Diabetes 28 (12.8) 14 (11.6) 14 (14.3)
Dyslipidemiab 72 (19.1) 34 (27.2) 38 (38.0) 0.084
Testosterone, ng/mL 1.83±1.24 1.97±1.33 1.64±1.09 0.008
LH, mIU/mL 17.8±8.4 19.0±8.9 16.3±7.5 0.003
FSH, mIU/mL 37.4±15.5 42.5±15.8 30.9±12.4 <0.001
Values are expressed as median (range), mean±SD, or number (%). Diabetes was defined as fasting plasma glucose (FPG) ≥126 mg/dL, glycated he-
moglobin (HbA1c) ≥6.5%, or current treatment with oral antidiabetes drugs or insulin. Prediabetes was defined as FPG between 100 and 125 mg/dL or 
an HbA1c of 5.7% to 6.4% and no diagnosis of diabetes. Hyperglycemia was diagnosed if the patient had diabetes, used hypoglycemic agents, or had a 
FPG ≥100 mg/dL or an HbA1c level ≥5.7%. Hypertension was diagnosed according to a systolic blood pressure ≥130 mm Hg, diastolic blood pressure 
≥85 mm Hg, or the use of antihypertensive medications. Dyslipidemia was defined as a serum total cholesterol level ≥240 mg/dL, triglyceride level ≥
150 mg/dL, low serum high density lipoprotein cholesterol level (<40 mg/dL in men and <50 mg/dL in women), or the use of lipid-lowering agents.
BMI, body mass index; LH, luteinizing hormone; FSH, follicle-stimulating hormone.
an=219; bn=223.
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DISCUSSION
The present study revealed that the prevalence of obesity in Ko-
rean men with KS is 42.6%, and that  testosterone level is an in-
dependent risk factor for obesity and hyperglycemia. Previous 
studies reported that even though patients with KS have abdom-
inal adiposity, their BMI is often in the normal range due to de-
creased muscle mass and increased body fat [8,9]. Although we 
were unable to compare patients with KS with age-matched 
healthy controls, the prevalence of obesity, based on the criteri-
on of a BMI ≥25 kg/m2, in Korean men with KS was higher 
than that in the general Korean male population. According to 
statistical data from Korea between 1998 and 2014, the preva-
lence of obesity in men aged ≥19 years was 25.1% to 37.7% 
[18]. Considering the mean age in the current study population 
was 32.5 years, the prevalence of obesity in KS seems rather 
higher than that of the general population. In Argentina, 62.5% 
of patients with KS had a BMI ≥25 kg/m2 [19].
Testosterone levels were an independent risk factor for obesi-
ty and glucose intolerance in the current study. This result is 
consistent with previous studies, which showed that  testosterone 
deficiency is a predictor of abdominal obesity and metabolic 
syndrome [8,9,20]. Testosterone may play a central role in met-
abolic syndrome and type 2 diabetes by increasing skeletal 
muscle mass and decreasing abdominal obesity and free fatty 
acids; therefore, it improves insulin resistance in men with a 
normal karyotype [21]. However, testosterone treatment in pa-
tients with KS does not fully correct the unfavorable body com-
position, although it is unclear whether adequate levels of tes-
tosterone were administered in these studies [8,22]. Further-
more, increased body fat mass is already present before puberty 
in boys with KS, which suggests that both genetic abnormalities 
and testosterone deficiency influence body fat in patients with 
KS [22].
Insulin resistance is the major pathogenesis of glucose intoler-
ance in patients with KS [8,23]. Lee et al. [10] used euglycemic 
hyperinsulinemic clamps to demonstrate impaired peripheral in-
sulin resistance as the mechanism underlying impaired glucose 
tolerance in Korean patients with KS. Recent both epidemiology 
and clinical studies showed clear evidence of a dramatically in-
creased risk of diabetes and metabolic syndrome in KS world-
wide [7]. In particular, In Korea, rapid economic development 
and a westernized lifestyle have resulted in increased rates of 
obesity [24]. Thus these factors can affect phenotype of KS.
The median total testosterone level in the current study was in 
the lower-to-normal range, whereas LH and FSH levels were 
increased, consistent with previous studies [1,8,9,19,25]. This 
suggests that hypogonadism in KS is relative rather than abso-
lute [4]. Among patients with KS, 45.1% to 56.5% have low to-
tal testosterone levels [19,25].
Less than 10% of the expected number of KS cases are diag-
nosed during childhood, and 15% to 20% of male KS cases are 
identified via investigations into the underlying cause of infertil-
ity [26,27]. The current data are consistent with these previous 
results, since 73% of patients with KS complained of infertility 
at the first consultation. Therefore, most Korean men with KS 
are not diagnosed until adulthood.
The current study has the strength of including a relatively 
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Fig. 1. Correlation among serum testosterone, body mass index (BMI), and fasting plasma glucose (FPG). (A) The association between tes-
tosterone and BMI. (B) The association between testosterone and FPG.
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large sample size. It is also the first report focusing on obesity in 
Korean patients with KS. Nevertheless, several limitations need 
to be considered. First, the retrospective design of the study did 
not allow any missing data to be collected. Relatively few phy-
sicians tend to measure metabolic parameters in patients with 
KS. Second, the present study was cross-sectional in nature, 
which prevents defining causal relationships. Third, the study 
was based on data from patients with KS from 11 university 
hospitals; therefore, the results need to be interpreted with cau-
tion before generalizing to the entire Korean population.
In conclusion, the current study describes the prevalence of 
obesity in Korean patients with KS for the first time. Hypogo-
nadism is a risk factor for obesity and hyperglycemia in patients 
with KS.
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